TBPP_Haptoglobin, Hemopexin

TBPP_Haptoglobin, Hemopexin

TBPP_Haptoglobin, Hemopexin


M. K.
This flashcard set delves into the biochemical and clinical aspects of haptoglobin and hemopexin, crucial proteins in managing heme and hemoglobin damage at the university level. It explores their roles in scavenging free heme and hemoglobin, preventing oxidative damage, inflammation, and cellular lysis, with a focus on conditions like sickle cell disease and acute hemolysis. The set also covers their purification processes, genetic and biochemical properties, and clinical applications, benefiting medical students and researchers seeking a comprehensive understanding of these proteins' functions and therapeutic potential.
Karten
9
Lernende
1
Sprache
Englisch
Kategorie
Chemie
Stufe
Universität
Erstellt / Aktualisiert
30.12.2016 / 05.01.2017

Lernkarten

genetics and biochemistry of Hemopexin (Hpx)

439 AS, single chain protein, 60 kD, 20% carbohydrate, 12 cysteines, 6 disulfide bonds, 0.5-1 mg/ml, homology and structure similar in all vertebrates, acute phase response induced Hpx expression in the liver, increases in response to free heme, other acute phase proteins unchanged, highest heme affinity, binds in equimolar ratio (1 heme), heme bound between 2 domains in a pocket: reversible binding by open/close of the pocket (via linker peptide)

function of Haptoglobin (Hp)

scavenging of cell-free hemoglobin, 1. erythrocyte lysis, 2. tetrameric a2b2 Hb dissociates in ab dimers, 3. ab-dimers bound with high affinity by Hp: prevents oxidative damage, 4. binding to CD163 receptor of a cell. Free Hb = oxidate hotspot, formation of toxic free radicals = inflammation and cytotoxicity, kidney and vascular damage, vasosconstriction (Verstopfung). Hb ab-dimers complexed with Hp are protected from oxidation.

function of Hemopexin (Hpx)

scavenges heme from circulation, physiological removal of old RBC: erythrophagocytosis by macrophages, heme degraded by HO-1, iron recycled, intravascular hemolysis (10%), massive hemolysis: free heme released, binding to albumin and transport to Hpx and then transport to liver. Hpx-heme complex binds to CD91 on hepatocytes, macrophages, neurons = endocytosis. other proteins activated by binding to receptor (for cellular defense)

further degradation of Heme/hemoglobin

1. degradation in lysosome, release of heme, 2. heme degradation by Hemoxigenase 1 to CO, Fe2+ and Biliverdin, 7. reduction of Biliverdin to Bilirubin, 5. Bilirubin transport to liver.

toxic actions of free heme

source of redox-active iron, produces ROS (damage, inflammation), intercalation into membranes: cell lysis and death, vascular leakage. Prevention by Hpx (no product available on the market)

purification from plasma

both proteins are precipitated in Fraction IV-4 and V, co-purification from fraction IC-4, extraction/amonium sulfate (salting out). Hemopexin: filtration --> chr. --> diafiltration/sterile filtration --> capto Q --> BioEX --> final concentration / DF, Haptoglobin: extraction --> chr. --> concentration/pasteurization --> dilution --> concentration / DF

clinical use perspective

acute or chronic hemolysis in which free Hb causes severe clinical issues. Haptoglobin marketed in Japan (acute hemolysis: burn, trauma, blood transfusion), HELLP syndrome (pregnant women), thermal injury, malaria, AB0 mismatched transfusion, acute infection, sickle cell disease (SCD)

sickle cell disease - overview

point mutation in Beta-Hb gene, aggregation of Beta-Hb, rigid and sickle-shaped RBC, prone to lysis, symptoms: pro-oxidative damage of free Hb and heme, vaso-occlusive crisis (pain, organ damage), major complications depend on age, heart attack or kidney fail cause to death, high heme concentration inside sickle RBC (lifespan 10-20 days), bone marrow cannot match rate of destruction: more sickle cells = chronic hemolysis, Haptoglobin and Hemopexin depleted in SCD.

Hp/Hpx treatment in SCD mice

Hpx protects the vascular endothelial system from oxidative damage, reduces inflammation (detoxification via liver)and iron accumulation, functional consequence: Hpx therapy normalizes blood pressure and cardiac output, measurements of stasis = vaso-occlusion after repetitive post injections: free Hb-infusion causes stasis, protection only by Hb, Hpx, and Hb+Hpx.

Lernen